Latest Linc News
Stay Informed on Linc Stock News: Access the latest Linc stock news, industry updates, and quick information on Linc stock buybacks,Linc results, Linc company analysis, Linc live prices, Linc dividends, Linc bonus share, board meetings, lifetime highs, Linc targets, lows, and growth stories with AI—all in one place.
Business Standard
Linc rallies after inking JV agreement with SILKA
Linc jumped 3.22% to Rs 748.90 after the company entered into joint venture agreement with Silka Kirtasiye Imalat Sanayi Ve Ticaret (SILKA) to carry out manufacturing of Writing Instruments in Turkiye.
•
Thu, Sep 26, 2024
Business Standard
Mitsubishi Pencil JV boosts Linc shares by 6%: details for investors
The joint venture taps into Mitsubishi's global writing instruments expertise and an annual turnover exceeding $500 million
•
Thu, Sep 26, 2024
Business Standard
Board of Linc approves JV with Mitsubishi Pencil Company
At its meeting held on 26 September 2024
•
Thu, Sep 26, 2024
The Economic Times
Tamil Nadu Chief Minister MK Stalin announced that the state has secured MoUs worth Rs 850 crores with US-based companies Lincoln Electric, Vishay Precision, and Visteon. Additionally, a Rs 2000 crore MoU was signed with Trilliant for a manufacturing unit and support centre. Further agreements were made with Nike, Optum, Eaton, and Assurant.
•
Fri, Sep 6, 2024
The Economic Times
Stock market update: Stocks that hit 52-week highs on NSE
Nupur Recyclers, Nectar Lifesc, Shriram EPC, Lincoln Pharma and Kothari Petro, hit their fresh 52-week highs at 11:05AM.
•
Thu, Sep 5, 2024
Business Standard
Lincoln Pharma Q1FY25 results: Net profit jumps 24% to Rs 23.67cr
Drug maker Lincoln Pharmaceuticals on Thursday said its consolidated net profit jumped by 24.51 per cent to Rs 23.67 crore in the April-June quarter of 2024-25 compared to Rs 19.01 crore in the year-ago quarter. Total income of the Ahmedabad-bnased company rose by 10 per cent to Rs 157.69 crore in the quarter under review from Rs 143.31 crore in the first quarter of 2023-24. Its operating profit (EBITDA) rose by 16.65 per cent to Rs 33.14 crore in the quarter from Rs 28.41 crore in Q1FY24. Both domestic and export operations have shown robust growth and the company is confident to enhance profitability and margins going forward, the company said in a statement. With focused growth strategies and business expansion plans for value added products and expanding to newer markets, the company is targeting revenue of Rs 750 crore in FY26, it said in the earnings statement. Lincoln Pharmaceuticals shares closed 0.95 per cent down at Rs 652.75 on BSE.
•
Thu, Aug 8, 2024
